sotalol has been researched along with pyrimidinones in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awaji, T; Haruno, A; Hashimoto, K; Hirasawa, A; Wu, Z; Xue, Y | 1 |
| Kanno, M; Nakaya, H; Takeda, Y; Tohse, N | 1 |
| Hara, Y; Masuda, Y; Mori, K; Nakaya, H; Saito, T | 1 |
| Ishii, K; Taira, N; Yamagishi, T | 1 |
| Mitamura, H; Ogawa, S; Okada, Y; Sadanaga, T | 1 |
| Endou, M; Hara, Y; Mori, K; Nakaya, H; Uemura, H | 1 |
| Cui, G; Sakaguchi, Y; Sen, L; Singh, BN | 1 |
| Kanmatuse, K; Kojima, T; Kunimoto, S; Masaki, R; Nakai, T; Oshikawa, N; Ozawa, Y; Saito, S; Watanabe, H; Watanabe, I | 1 |
| Ito, H; Maruyama, T | 1 |
| Fujiki, A | 1 |
| Aizawa, Y; Chinushi, M; Furushima, H; Hirono, T; Hosaka, Y; Komura, S; Sugiura, H; Tanabe, Y; Washizuka, T; Watanabe, H | 1 |
| Maeda, K; Nakagawa, E; Takagi, M; Tatsumi, H; Yoshiyama, M | 1 |
| Koyfman, A; Long, B | 1 |
3 review(s) available for sotalol and pyrimidinones
| Article | Year |
|---|---|
[Recent findings on the dromotropic actions of the class III antiarrhythmic agents].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Neural Conduction; Pyrimidinones; Sotalol | 2002 |
[Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bepridil; Drug Therapy, Combination; Humans; Pyrimidinones; Sotalol | 2006 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Evidence-Based Medicine; Humans; Lidocaine; Procainamide; Pyrimidinones; Review Literature as Topic; Sotalol; Tachycardia, Ventricular | 2017 |
3 trial(s) available for sotalol and pyrimidinones
| Article | Year |
|---|---|
Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography.
Topics: Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Female; Humans; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Piperidines; Pyridines; Pyrimidinones; Regression Analysis; Sotalol; Statistics, Nonparametric; Sulfonamides | 1996 |
Comparison of efficacy of sotalol and nifekalant for ventricular tachyarrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Heart Diseases; Humans; Male; Middle Aged; Pyrimidinones; Secondary Prevention; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2006 |
The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiography; Female; Humans; Male; Middle Aged; Pyrimidinones; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function, Left | 2008 |
7 other study(ies) available for sotalol and pyrimidinones
| Article | Year |
|---|---|
Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Female; Halothane; Ligation; Male; Myocardial Reperfusion; Pentobarbital; Pyrimidinones; Sotalol; Ventricular Fibrillation | 1995 |
Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cell Membrane; Electric Stimulation; Heart; Heart Rate; Heart Ventricles; In Vitro Techniques; Ion Channels; Membrane Potentials; Myocardial Contraction; Myocardium; Papillary Muscles; Potassium Channels; Pyrimidinones; Rabbits; Refractory Period, Electrophysiological; Sotalol | 1993 |
Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.
Topics: Acetylcholine; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Cells, Cultured; Guinea Pigs; Heart Atria; In Vitro Techniques; Myocardial Contraction; Patch-Clamp Techniques; Piperidines; Potassium Channels; Pyridines; Pyrimidinones; Receptors, Muscarinic; Sotalol | 1995 |
Absence of effects of class III antiarrhythmic agents on cloned cardiac K channels.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Cloning, Molecular; Electrophysiology; Myocardium; Oocytes; Piperidines; Potassium Channels; Pyridines; Pyrimidinones; Quinidine; Sotalol; Xenopus laevis | 1993 |
Interaction of class III antiarrhythmic drugs with muscarinic M2 and M3 receptors: radioligand binding and functional studies.
Topics: Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Myocardial Contraction; N-Methylscopolamine; Pyrimidinones; Radioligand Assay; Receptors, Muscarinic; Scopolamine Derivatives; Sotalol | 1995 |
Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Dogs; Electrocardiography; Epinephrine; Heart; Male; Pyrimidinones; Refractory Period, Electrophysiological; Sotalol | 1998 |
Frequency-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium.
Topics: Action Potentials; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Cohort Studies; Drug Evaluation; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Atria; Humans; Middle Aged; Pyrimidinones; Sotalol | 2001 |